BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7357558)

  • 1. Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors.
    Ganzinger U; Deutsch E
    Cancer Res; 1980 Apr; 40(4):1300-4. PubMed ID: 7357558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum deoxythymidine-5'-triphosphatase activity as a parameter in the diagnosis and follow-up of large bowel carcinoma.
    Dahlmann N; Pompecki R
    Cancer Res; 1984 Feb; 44(2):848-51. PubMed ID: 6318978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzymes in tumors of the large intestine].
    Przewłocki T
    Patol Pol; 1982; 33(1-2):39-50. PubMed ID: 6813817
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum sialyltransferase activity in benign and malignant diseases.
    Ronquist G; Rimsten A; Westman M; Cervén E
    Acta Chir Scand; 1980; 146(4):247-52. PubMed ID: 7468050
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer.
    Dao TL; Ip C; Patel J
    J Natl Cancer Inst; 1980 Sep; 65(3):529-34. PubMed ID: 6251302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients.
    Silver HK; Karim KA; Archibald EL; Salinas FA
    Cancer Res; 1979 Dec; 39(12):5036-42. PubMed ID: 498130
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum glycosyl transferases and carcinoembryonic antigen in patients with colorectal carcinoma in different stages.
    Ronquist G; Rimsten A; Blanche C; Cervén E; Hiesche C; Westman M
    Acta Chir Scand; 1982; 148(4):373-7. PubMed ID: 7136442
    [No Abstract]   [Full Text] [Related]  

  • 9. Sialyl transferase activity: a serum enzyme marker in the follow-up of cancer patients.
    Ganzinger U; Moser K
    Recent Results Cancer Res; 1979; 67():50-5. PubMed ID: 451323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum, tumor, and liver serum glycoprotein: N-acetylneuraminic acid transferase activity with growth of the R3230AC mammary tumor in rats and relationship of the serum activity to tumor burden.
    Evans IM; Hilf R; Murphy M; Bosmann HB
    Cancer Res; 1980 Sep; 40(9):3103-11. PubMed ID: 7427928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in platelet surface sialytransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis.
    Scialla SJ; Speckart SF; Haut MJ; Kimball DB
    Cancer Res; 1979 Jun; 39(6 Pt 1):2031-5. PubMed ID: 445401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of serum phosphohexose isomerase and sialyl transferase activities in patients with malignant disease].
    Bayer PM; Ganzinger U; Burger EC; Gergely T; Gabl F; Moser K
    Wien Klin Wochenschr; 1977 Jan; 89(1):16-7. PubMed ID: 556872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in serum glycosyltransferases and 5'-nucleotidase in breast cancer patients.
    Ip C; Dao T
    Cancer Res; 1978 Mar; 38(3):723-8. PubMed ID: 626976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of some serum enzymes in patients with malignant gastrointestinal tumors].
    Pipino G; Agrifoglio G; Cassina I
    Minerva Med; 1969 Jun; 60(47):2325-33. PubMed ID: 5790473
    [No Abstract]   [Full Text] [Related]  

  • 15. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between plasma carcinoembryonic antigen (CEA) and sialyltransferase as tumor marker.
    Dwivedi C; Dixit M; Hardy RE
    J Med; 1984; 15(5-6):379-84. PubMed ID: 6599115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum sialyltransferase follow up control of malignant diseases].
    Ganzinger U; Euler-Rolle J; Baumgartner G; Pawlak E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1212-5. PubMed ID: 206046
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum-sialyltransferase activity in cancer patients.
    Berge PG; Wilhelm A; Schriewer H; Wüst G
    Klin Wochenschr; 1982 May; 60(9):445-9. PubMed ID: 7045508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.
    Hardt PD; Ngoumou BK; Rupp J; Schnell-Kretschmer H; Kloer HU
    Anticancer Res; 2000; 20(6D):4965-8. PubMed ID: 11326648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma sialyltransferase as a tumor marker.
    Dwivedi C; Dixit M; Hardy RE
    Cancer Detect Prev; 1988; 11(3-6):191-6. PubMed ID: 3390843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.